Nurix Therapeutics, Inc.NRIXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+18.6%
5Y CAGR+35.9%
Year-over-Year Change
Research and development spending
3Y CAGR
+18.6%/yr
vs +46.1%/yr prior
5Y CAGR
+35.9%/yr
Recent deceleration
Acceleration
-27.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.6x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $308.16M | +39.0% |
| 2024 | $221.63M | +17.2% |
| 2023 | $189.15M | +2.5% |
| 2022 | $184.50M | +58.5% |
| 2021 | $116.43M | +75.1% |
| 2020 | $66.49M | +47.7% |
| 2019 | $45.02M | +11.1% |
| 2018 | $40.51M | - |